International Journal of Endocrinology and Metabolism
Research Institute for Endocrine Sciences
Scopus by Title (Ref)
Articles that cite the referenced work, matched by title from the Scopus database.
Complications after radiotherapy in patients with Graves’ orbitopathy: A nationwide cohort study
Eye Basingstoke
May 2026
Lee J.
Open Access
Early Low-Dose Rituximab for Mild-to-Moderate Thyroid Eye Disease: A Preliminary Evaluation of Efficacy and Safety
International Journal of Endocrinology
2026
Lu M.
Open Access
Thyroid eye disease: Established and emerging therapies
Best Practice and Research Clinical Endocrinology and Metabolism
2026
Samia-Aly E.
Radiotherapy for Nonmalignant Eye Diseases: Graves’ Ophthalmopathy – Pseudotumor Orbitae
Seminars in Radiation Oncology
January 2026
Seegenschmiedt M.H.
Combining orbital intensity modulated radiation therapy with periorbital triamcinolone acetonide injection for Graves’ orbitopathy
International Journal of Ophthalmology
18 May 2025
Jian H.
Open Access
No retinopathy after orbital irradiation in patients with thyroid eye disease – a follow up study
Frontiers in Endocrinology
2025
Makhoul S.
Open Access
Ocular manifestations in Hashimoto's thyroiditis and Graves' disease
Ophthatherapy Therapies in Ophthalmology
January 2025
Malon P.
Open Access
Late orbital radiotherapy combined with intravenous methylprednisolone in the management of long-lasting active graves’ orbitopathy: a case report and literature review
Endocrine
August 2024
Verrienti M.
Open Access
Management of Graves’ ophthalmopathy by radiotherapy: A literature review
Cancer Radiotherapie
June 2024
Beige A.
Stereotactic radiotherapy of radiation-induced meningioma previously irradiated retrobulbar for Graves' ophthalmopathy: A case report
Radiology Case Reports
March 2024
Tachizawa N.
Open Access
Novel Immunomodulatory Treatment Modalities for Thyroid-Associated Orbitopathy
Oculoplastic Lacrimal and Orbital Surgery the Esoprs Textbook Volume 2
1 January 2024
Strianese D.
Changes in therapeutic response, ocular manifestations of Graves’ orbitopathy and quality of life during the first year after orbital radiotherapy
International Ophthalmology
November 2023
Stoynova M.A.
Advances in the Treatment of Thyroid Eye Disease Associated Extraocular Muscle Myopathy and Optic Neuropathy
Current Neurology and Neuroscience Reports
June 2022
Lu T.J.
All Open Access, Green
Orbital Radiation for Thyroid Eye Disease: A Report by the American Academy of Ophthalmology
Ophthalmology
April 2022
Sobel R.K.
Graves’ orbitopathy: diagnosis, epidemiology and treatments
Revue De Medecine Interne
April 2022
Lun A.Y.
Discussion on treatment of thyroid associated ophthalmopathy based on "state-target theory" with Traditional Chinese Medicine
China Journal of Chinese Ophthalmology
30 January 2022
Han X.
Orbital radiotherapy for proptosis in patients with Graves’ ophthalmopathy
Therapeutic Radiology and Oncology
September 2021
Ding B.Y.
Open Access
Current Role and Historical Roots of Radiotherapy in Thyroid Eye Disease
International Ophthalmology Clinics
Spring 2021
Siktberg J.
Thyroid eye disease: Redefining its management—A review
Clinical and Experimental Ophthalmology
March 2021
Jain A.P.
The role of autophagy in thyroid-related ophthalmopathy
International Eye Science
8 February 2021
Yuan S.S.
Is concomitant treatment with steroids and radiotherapy more favorable than sequential treatment in moderate-to-severe graves orbitopathy?
Radiologia Medica
February 2021
Limone P.P.
All Open Access, Green
Teprotumumab: a novel therapeutic monoclonal antibody for thyroid-associated ophthalmopathy
Expert Opinion on Investigational Drugs
2 July 2020
Slentz D.H.
All Open Access, Green
Current Understanding of the Progression and Management of Thyroid Associated Orbitopathy: A Systematic Review
Ophthalmology and Therapy
1 March 2020
Hodgson N.M.
Open Access